3622 results for «487»

Filter By

3622 results

Valve-in-valve: the journey starts with the first prosthesis

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...

Valve-in-valve: the journey starts with the first prosthesis

The cathlab of the future

17 May 2022 – From EuroPCR 2022

Let's take the practical case of an 84-year-old male patient with hypertension, dyslipidaemia, and severe aortic stenosis: in this EuroPCR 2022 session, find out how to treat such a patient in the cathlab of the future and discuss the benefits of non-invasive technology at tableside, tools...

The cathlab of the future

What's next in DES technology? Innovative DES platforms combining DES with DCB

19 May 2022 – From EUROPCR 2022

Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...

What's next in DES technology? Innovative DES platforms combining DES with DCB

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

Start treating refractory angina patients with Reducer therapy - Practical aspects

17 May 2022 – From EuroPCR 2022

Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

Start treating refractory angina patients with Reducer therapy - Practical aspects

DCB and the possibility of a clean vessel

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

DCB and the possibility of a clean vessel

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients

Left main and complex bifurcation PCI in high bleeding risk patients

View the life challenging case of a 90-year-old male patient with a very active lifestyle but hypertension, dyslipidemia, ex-smoker, who presented with left main bifurcation lesion, and appreciate the value of transradial approach for left main and complex bifurcation PCI, acknowledge Ultimaster DES results in bifurcations and high...

Left main and complex bifurcation PCI in high bleeding risk patients

Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for

18 May 2022 – From EuroPCR 2022

Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO...

Cre8 EVO: the 'sweetest advancement' that a diabetic patient is waiting for

Transradial approach, from complex PCI to peripheral intervention

19 May 2022 – From EUROPCR 2022

Watch this session if you want to demonstrate how to optimise challenging coronary and peripheral cases using dedicated devices in transradial approach, to appreciate the value of transradial approach for complex PCI and carotid artery stenting and to acknowledge Ultimaster DES results in high bleeding risk patient...

Transradial approach, from complex PCI to peripheral intervention

Conquer calcium with intravascular lithotripsy (IVL): cases and clinical data

18 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session mainly focuses on the DISRUPT CAD studies: hear discussion on the latest DISRUPT CAD clinical evidence supporting the use of IVL across different calcium morphologies, appraise the most recent one-year OCT-pooled analysis of the DISRUPT CAD III and IV studies, and learn about the differences...

Conquer calcium with intravascular lithotripsy (IVL): cases and clinical data

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

18 May 2022 – From EuroPCR 2022

What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things

18 May 2022 – From EuroPCR 2022

Based on the didactic analysis of several practical cases, and also on the latest guidelines and study outcomes on the subject, learn in this EuroPCR 2022 session new management strategies to optimise PCI in diffuse coronary artery disease, new developments of the Optowire to support decision-making in patients...

The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things

Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions

18 May 2022 – From EuroPCR 2022

Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...

Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions

From access to closure in transcatheter valve procedures - Optimising patients' outcomes step by step

18 May 2022 – From EUROPCR 2022

Watch this EuroPCR 2022 session to learn the key steps in transcatheter mitral valve repair and transcatheter aortic valve implantation procedures. 
Follow step by step how to optimally access and close venous large bore access sites using suture mediated vessel closure devices, and learn about the key...

From access to closure

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve

18 May 2022 – From EuroPCR 2022

The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent and VitaFlow valve
Didn’t find what you were looking for?